Cargando…
PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity
Metabolic rewiring and defective immune responses are considered to be the main driving forces sustaining cell growth and oncogenesis in many cancers. The atypical enzyme, proprotein convertase subtilisin/kexin type 9 (PCSK9), is produced by the liver in large amounts and plays a major role in lipid...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777286/ https://www.ncbi.nlm.nih.gov/pubmed/36552895 http://dx.doi.org/10.3390/cells11244132 |